29 results
8-K
PTPI
Petros Pharmaceuticals Inc
28 Dec 23
Departure of Directors or Certain Officers
4:05pm
will vest upon the achievement of certain strategic goals during 2023 and 2024, provided that Mr. Boctor remains employed by the Company on the applicable
424B3
PTPI
Petros Pharmaceuticals Inc
19 Sep 23
Prospectus supplement
4:36pm
to pursue out strategic goals, including our Non-Prescription / OTC strategies related to Stendra®. If we do not obtain any such additional financing … , it may be difficult to effectively realize our long-term strategic goals and objectives.
Our current cash resources will not be sufficient to fund
POS AM
xh6rbn3
14 Oct 22
Prospectus update (post-effective amendment)
4:05pm
PRE 14A
th2p5xoqehz
30 Sep 22
Preliminary proxy
4:45pm
424B3
8h9mh mo3qn5u4djo73
14 Jan 22
Prospectus supplement
5:18pm
424B5
xrcbr0
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
j7cwsoxewni7v4cf5c4c
1 Dec 21
Prospectus supplement for primary offering
5:10pm
DEF 14A
n6tqcirh6 53fkpv
22 Nov 21
Definitive proxy
4:37pm